Smartleaf Asset Management’s IGC Pharma IGC Stock Holding History

Smartleaf Asset Management’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Buy	+2	New	+$1	﹤0.01%	3625

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Schneider Downs Wealth Management Advisors Pittsburgh, Pennsylvania $1.08B AUM 10.9% 1-Year Est. Return

Wealthcare Advisory Partners West Chester, Pennsylvania $5.9B AUM 14.62% 1-Year Est. Return

Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Smartleaf Asset Management's IGC Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in IGC Pharma (IGC) in Q3 2026: 2 shares worth $1. The stake represents ﹤0.01% of the portfolio and ranks #3625 among its holdings.

15 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

Smartleaf Asset Management held 2 shares of IGC Pharma worth $1 as of Q3 2026.
IGC Pharma was a new Smartleaf Asset Management position in Q3 2026.
IGC Pharma made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3625 holding.
15 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.